New research published in the Annals of Clinical and Translational Neurology has identified three genes and their expressed proteins that may be involved in the pathogenesis of multiple sclerosis.

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...

Multiple sclerosis (MS) is the most common disabling disease of the central nervous system (CNS) in young adults. The disease is initiated when activated autoreactive T cells infiltrate the CNS and ...

Multiple sclerosis (MS) is a complex autoimmune disorder in which aberrant immune responses target the myelin sheath of central nervous system axons, leading to neuroinflammation, demyelination and ...

MicroRNAs are short non-coding RNA molecules that fine-tune gene expression in immune and neural cells. In multiple sclerosis, dysregulated microRNA networks contribute to the imbalance between ...

In a recent article published in the Clinical and Translational Immunology journal, researchers pursuing multiple sclerosis (MS) therapies and preventive interventions reviewed the current evidence ...

Scientists uncover how shifts in gut fungi, shaped by genes and diet, may influence disease severity in people with multiple sclerosis, paving the way for new microbiome-based treatments. Study: ...

A team of scientists from the New York Stem Cell Foundation (NYSCF) Research Institute and Case Western Reserve University has created the largest reported collection of stem cell models from multiple ...

Some types of CD8+ T cells (killer T cells) may play a role in the development of multiple sclerosis (MS). This is according to data from a new study published in Nature Immunology. Specifically, ...

More research is necessary to understand cerebral oxygen consumption as a predictive biomarker for brain atrophy in multiple sclerosis (MS); however, this study found that mitochondrial dysfunction ...

Olfactory dysfunction in MS may be linked to nasal microbial changes, not just central inflammation. MS patients showed lower olfactory test scores and distinct nasal microbiome differences compared ...